Clinical Genomic Analyses Demonstrate t(11;14) Multiple Myeloma Retains B-Cell Biology and Distinct Mitochondrial Metabolism That Convey Increased Sensitivity to BCL-2 Inhibition By Venetoclax
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 4242-4244
10.1182/blood-2022-160195